Eukaryotic elongation factor 2 kinase, an unusual enzyme with multiple roles

Advances in Biological Regulation

Volumn 55, Issue , 2014, Pages 15-27

  Kenney, Justin W ^a   Moore, Claire E ^a   Wang, Xuemin ^a   Proud, Christopher G ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Calmodulin; EEF2; MRNA translation; MTORC1; Protein synthesis

Indexed keywords

CALCIUM; ELONGATION FACTOR 2 KINASE; GLUTAMIC ACID; TARGET OF RAPAMYCIN KINASE;

ANTAGONISTS AND INHIBITORS; AUTOPHAGY; CELL PROTECTION; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; NEOPLASM; PATHOPHYSIOLOGY; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; SYNAPTIC TRANSMISSION;

AUTOPHAGY; CALCIUM; CYTOPROTECTION; ELONGATION FACTOR 2 KINASE; GENE EXPRESSION REGULATION; GLUTAMIC ACID; HUMANS; MUSCLE, SKELETAL; NEOPLASMS; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; TOR SERINE-THREONINE KINASES;

EID: 84901463783     PISSN: 22124926     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.jbior.2014.04.003     Document Type: Review

References (110)

1. Arora S., Yang J.M., Hait W.N. Identification of the ubiquitin-proteasome pathway in the regulation of the stability of eukaryotic elongation factor-2 kinase. Cancer Res 2005, 65:3806-3810.
2. Arora S., Yang J.M., Kinzy T.G., Utsumi R., Okamoto T., Kitayama T., et al. Identification and characterization of an inhibitor of eukaryotic elongation factor 2 kinase against human cancer cell lines. Cancer Res 2003, 63:6894-6899.
3. Autry A.E., Adachi M., Nosyreva E., Na E.S., Los M.F., Cheng P.F., et al. NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature 2011, 475:91-95.
4. Belelovsky K., Elkobi A., Kaphzan H., Nairn A.C., Rosenblum K. A molecular switch for translational control in taste memory consolidation. Eur J Neurosci 2005, 22:2560-2568.
5. Bramham C.R., Panja D. BDNF regulation of synaptic structure, function, and plasticity. Neuropharmacology 2014, 76(Pt C):601-602.
6. Browne G.J., Finn S.G., Proud C.G. Stimulation of the AMP-activated protein kinase leads to activation of eukaryotic elongation factor 2 kinase and to its phosphorylation at a novel site, serine 398. J Biol Chem 2004, 279:12220-12231.
7. Brugarolas J., Lei K., Hurley R.L., Manning B.D., Reiling J.H., Hafen E., et al. Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes Dev 2004, 18:2893-2904.
8. Buttgereit F., Brand M.D. A hierarchy of ATP-consuming processes in mammalian cells. Biochem J 1995, 312(Pt 1):163-167.
9. Carlberg U., Nilsson A., Nygard O. Functional properties of phosphorylated elongation factor 2. Eur J Biochem 1990, 191:639-645.
10. Chan E.Y. mTORC1 phosphorylates the ULK1-mAtg13-FIP200 autophagy regulatory complex. Sci Signal 2009, 2. e51.
11. Chen Z., Gopalakrishnan S.M., Bui M.H., Soni N.B., Warrior U., Johnson E.F., et al. 1-Benzyl-3-cetyl-2-methylimidazolium iodide (NH125) induces phosphorylation of eukaryotic elongation factor-2 (eEF2): a cautionary note on the anticancer mechanism of an eEF2 kinase inhibitor. J Biol Chem 2011, 286:43951-43958.
12. Cheng Y., Li H., Ren X., Niu T., Hait W.N., Yang J. Cytoprotective effect of the elongation factor-2 kinase-mediated autophagy in breast cancer cells subjected to growth factor inhibition. PLoS ONE 2010, 5. e9715.
13. Cheng Y., Ren X., Zhang Y., Patel R., Sharma A., Wu H., et al. eEF-2 kinase dictates cross-talk between autophagy and apoptosis induced by Akt Inhibition, thereby modulating cytotoxicity of novel Akt inhibitor MK-2206. Cancer Res 2011, 71:2654-2663.
14. Cheng Y., Ren X., Zhang Y., Shan Y., Huber-Keener K.J., Zhang L., et al. Integrated regulation of autophagy and apoptosis by EEF2K controls cellular fate and modulates the efficacy of curcumin and velcade against tumor cells. Autophagy 2012, 9.
15. Chu H.P., Liao Y., Novak J.S., Hu Z., Merkin J.J., Shymkiv Y., et al. Germline quality control: eEF2K stands guard to eliminate defective oocytes. Dev Cell 2014, 28:561-572.
16. Connolly E., Braunstein S., Formenti S., Schneider R.J. Hypoxia inhibits protein synthesis through a 4E-BP1 and elongation factor 2 kinase pathway controlled by mTOR and uncoupled in breast cancer cells. Mol Cell Biol 2006, 26:3955-3965.
17. Crawley S.W., Cote G.P. Determinants for substrate phosphorylation by Dictyostelium myosin II heavy chain kinases A and B and eukaryotic elongation factor-2 kinase. Biochim Biophys Acta 2008, 1784:908-915.
18. Crawley S.W., Gharaei M.S., Ye Q., Yang Y., Raveh B., London N., et al. Autophosphorylation activates Dictyostelium myosin II heavy chain kinase A by providing a ligand for an allosteric binding site in the alpha-kinase domain. J Biol Chem 2011, 286:2607-2616.
19. Davies S.P., Reddy H., Caivano M., Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 2000, 351:95-105.
20. Devkota A.K., Tavares C.D., Warthaka M., Abramczyk O., Marshall K.D., Kaoud T.S., et al. Investigating the kinetic mechanism of inhibition of elongation factor 2 kinase by NH125: evidence of a common in vitro artifact. Biochemistry 2012, 51:2100-2112.
21. Devkota A.K., Warthaka M., Edupuganti R., Tavares C.D., Johnson W.H., Ozpolat B., et al. High-throughput screens for eEF-2 kinase. J Biomol Screen 2013, 19:445-452.
22. Diggle T.A., Redpath N.T., Heesom K.J., Denton R.M. Regulation of protein synthesis elongation factor-2 kinase by cAMP in adipocytes. Biochem J 1998, 336:525-529.
23. 2+/calmodulin-independent activity. Biochem J 2001, 353:621-626.
24. Dorovkov M.V., Pavur K.S., Petrov A.N., Ryazanov A.G. Regulation of elongation factor-2 kinase by pH. Biochemistry 2002, 41:13444-13450.
25. Dunlop E.A., Tee A.R. The kinase triad, AMPK, mTORC1 and ULK1, maintains energy and nutrient homoeostasis. Biochem Soc Trans 2013, 41:939-943.
26. Efeyan A., Zoncu R., Sabatini D.M. Amino acids and mTORC1: from lysosomes to disease. Trends Mol Med 2012, 18:524-533.
27. Egan D., Kim J., Shaw R.J., Guan K.L. The autophagy initiating kinase ULK1 is regulated via opposing phosphorylation by AMPK and mTOR. Autophagy 2011, 7:643-644.
28. Eley H.L., Russell S.T., Tisdale M.J. Effect of branched-chain amino acids on muscle atrophy in cancer cachexia. Biochem J 2007, 407:113-120.
29. Gerber N.U., Mynarek M., von H.K., Friedrich C., Resch A., Rutkowski S. Recent developments and current concepts in medulloblastoma. Cancer Treat Rev 2013, 40:356-365.
30. Gildish I., Manor D., David O., Sharma V., Williams D., Agarwala U., et al. Impaired associative taste learning and abnormal brain activation in kinase-defective eEF2K mice. Learn Mem 2012, 19:116-125.
31. Gonzalez-Teran B., Cortes J.R., Manieri E., Matesanz N., Verdugo A., Rodriguez M.E., et al. Eukaryotic elongation factor 2 controls TNF-alpha translation in LPS-induced hepatitis. J Clin Invest 2012, 123:164-178.
32. Gronli J., Soule J., Bramham C.R. Sleep and protein synthesis-dependent synaptic plasticity: impacts of sleep loss and stress. Front Behav Neurosci 2013, 7:224.
33. Gschwendt M., Kittstein W., Marks F. Elongation factor-2 kinase: effective inhibition by the novel protein kinase inhibitor rottlerin and relative insensitivity towards staurosporine. FEBS Lett 1994, 338:85-88.
34. Gwinn D.M., Shackelford D.B., Egan D.F., Mihaylova M.M., Mery A., Vasquez D.S., et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell 2008, 30:214-226.
35. Hannan K.M., Sanij E., Hein N., Hannan R.D., Pearson R.B. Signaling to the ribosome in cancer-It is more than just mTORC1. IUBMB Life 2011, 63:79-85.
36. Hardie D.G., Ross F.A., Hawley S.A. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol 2012, 13:251-262.
37. Hizli A.A., Chi Y., Swanger J., Carter J.H., Liao Y., Welcker M., et al. Phosphorylation of eukaryotic elongation factor 2 (eEF2) by cyclin A-cyclin-dependent kinase 2 regulates its inhibition by eEF2 kinase. Mol Cell Biol 2013, 33:596-604.
38. Hori H., Nagasawa H., Ishibashi M., Uto Y., Hirata A., Saijo K., et al. TX-1123: an antitumor 2-hydroxyarylidene-4-cyclopentene-1,3-dione as a protein tyrosine kinase inhibitor having low mitochondrial toxicity. Bioorg Med Chem 2002, 10:3257-3265.
39. Horman S., Beauloye C., Vertommen D., Vanoverschelde J.L., Hue L., Rider M.H. Myocardial ischemia and increased heart work modulate the phosphorylation state of eukaryotic elongation factor-2. J Biol Chem 2003, 278:41970-41976.
40. Im H.I., Nakajima A., Gong B., Xiong X., Mamiya T., Gershon E.S., et al. Post-training dephosphorylation of eEF-2 promotes protein synthesis for memory consolidation. PLoS ONE 2009, 4. e7424.
41. Inoki K., Zhu T., Guan K.L. TSC2 mediates cellular energy response to control cell growth and survival. Cell 2003, 115:577-590.
42. Kaelin W.G., Ratcliffe P.J. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell 2008, 30:393-402.
43. Kang H., Schuman E.M. A requirement for local protein synthesis in neurotrophin-induced hippocampal synaptic plasticity. Science 1996, 273:1402-1406.
44. Kanhema T., Dagestad G., Panja D., Tiron A., Messaoudi E., Havik B., et al. Dual regulation of translation initiation and peptide chain elongation during BDNF-induced LTP in vivo: evidence for compartment-specific translation control. J Neurochem 2006, 99:1328-1337.
45. Kimball S.R., Jefferson L.S. Signaling Pathways and Molecular Mechanisms through which branched-chain amino acids mediate translational control of protein synthesis. J Nutr 2006, 136:227S-231S.
46. Knebel A., Morrice N., Cohen P. A novel method to identify protein kinase substrates: eEF2 kinase is phosphorylated and inhibited by SAPK4/p38delta. EMBO J 2001, 20:4360-4369.
47. Knebel A., Haydon C.E., Morrice N., Cohen P. Stress-induced regulation of eEF2 kinase by SB203580-sensitive and -insensitive pathways. Biochem J 2002, 367:525-532.
48. Kruiswijk F., Yuniati L., Magliozzi R., Low T.Y., Lim R., Bolder R., et al. Coupled activation and degradation of eEF2K regulates protein synthesis in response to genotoxic stress. Sci Signal 2012, 5. ra40.
49. Kurino M., Fukunaga K., Ushio Y., Miyamoto E. Activation of mitogen-activated protein kinase in cultured rat hippocampal neurons by stimulation of glutamate receptors. J Neurochem 1995, 65:1282-1289.
50. Lenz G., Avruch J. Glutamatergic regulation of the p70S6 kinase in primary mouse neurons. J Biol Chem 2005, 280:38121-38124.
51. Leprivier G., Remke M., Rotblat B., Dubuc A., Mateo A.R., Kool M., et al. The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongation. Cell 2013, 153:1064-1079.
52. Liu-Yesucevitz L., Bassell G.J., Gitler A.D., Hart A.C., Klann E., Richter J.D., et al. Local RNA translation at the synapse and in disease. J Neurosci 2011, 31:16086-16093.
53. Marin P., Nastiuk K.L., Daniel N., Girault J., Czernik A.J., Glowinski J., et al. Glutamate dependent phosphorylation of elongation factor 2 and inhibition of protein synthesis in neurons. J Neurosci 1997, 17:3445-3454.
54. Martin K.C., Casadio A., Zhu H., Yaping E., Rose J.C., Chen M., et al. Synapse-specific, long-term facilitation of aplysia sensory to motor synapses: a function for local protein synthesis in memory storage. Cell 1997, 91:927-938.
55. McLeod L.E., Wang L., Proud C.G. β-Adrenergic agonists increase phosphorylation of elongation factor 2 in cardiomyocytes without eliciting calcium-independent eEF2 kinase activity. FEBS Lett 2001, 489:225-228.
56. Merrick W.C. Eukaryotic protein synthesis: still a mystery. J Biol Chem 2010, 285:21197-21201.
57. Middelbeek J., Clark K., Venselaar H., Huynen M.A., van Leeuwen F.N. The alpha-kinase family: an exceptional branch on the protein kinase tree. Cell Mol Life Sci 2010, 67:875-890.
58. Miranda L., Horman S., De P.I., Hue L., Jensen J., Rider M.H. Effects of contraction and insulin on protein synthesis, AMP-activated protein kinase and phosphorylation state of translation factors in rat skeletal muscle. Pflugers Arch 2008, 455:1129-1140.
59. Mittl P.R., Schneider-Brachert W. Sel1-like repeat proteins in signal transduction. Cell Signal 2007, 19:20-31.
60. Miyashiro K., Dichter M., Eberwine J. On the nature and differential distribution of mRNAs in hippocampal neurites: implications for neuronal functioning. Proc Natl Acad Sci U S A 1994, 91:10800-10804.
61. Monteggia L.M., Gideons E., Kavalali E.T. The role of eukaryotic elongation factor 2 kinase in rapid antidepressant action of ketamine. Biol Psychiatry 2012, 73:1199-1203.
62. Nairn A.C., Bhagat B., Palfrey H.C. Identification of calmodulin-dependent protein kinase III and its major Mr 100,000 substrate in mammalian tissues. Proc Natl Acad Sci USA 1985, 82:7939-7943.
63. Nairn A.C., Matsushita M., Nastiuk K., Horiuchi A., Mitsui K.-I., Shimizu Y., et al. Elongation factor-2 phosphorylation and the regulation of protein synthesis by calcium. Prog Mol Subcell Biol 2001, 27:91-129.
64. Palmquist K., Riis B., Nilsson A., Nygard O. Interaction of the calcium and calmodulin regulated eEF-2 kinase with heat shock protein 90. FEBS Lett 1994, 349:239-242.
65. Park S., Park J.M., Kim S., Kim J.A., Shepherd J.D., Smith-Hicks C.L., et al. Elongation factor 2 and fragile X mental retardation protein control the dynamic translation of Arc/Arg3.1 essential for mGluR-LTD. Neuron 2008, 59:70-83.
66. Parks S.K., Chiche J., Pouyssegur J. Disrupting proton dynamics and energy metabolism for cancer therapy. Nat Rev Cancer 2013, 13:611-623.
67. Parmer T.G., Ward M.D., Yurkow E.J., Vyas V.H., Kearney T.J., Hait W.N. Activity and regulation by growth factors of calmodulin-dependent protein kinase III (elongation factor 2-kinase) in human breast cancer. Br J Cancer 1999, 79:59-64.
68. Pavur K.S., Petrov A.N., Ryazanov A.G. Mapping the functional domains of elongation factor-2 kinase. Biochemistry 2000, 39:12216-12224.
69. Pigott C.R., Mikolajek H., Moore C.E., Finn S.J., Phippen C.W., Werner J.M., et al. Insights into the regulation of eukaryotic elongation factor 2 kinase and the interplay between its domains. Biochem J 2011, 442:105-118.
70. Pineiro D., Gonzalez V.M., Hernandez-Jimenez M., Salinas M., Martin M.E. Translation regulation after taxol treatment in NIH3T3 cells involves the elongation factor (eEF)2. Exp Cell Res 2007, 313:3694-3706.
71. Price N.T., Redpath N.T., Severinov K.V., Campbell D.G., Russell J.M., Proud C.G. Identification of the phosphorylation sites in elongation factor-2 from rabbit reticulocytes. FEBS Lett 1991, 282:253-258.
72. Proud C.G. mTORC1 regulates the efficiency and cellular capacity for protein synthesis. Biochem Soc Trans 2013, 41:923-926.
73. Py B.F., Boyce M., Yuan J. A critical role of eEF-2K in mediating autophagy in response to multiple cellular stresses. Autophagy 2009, 5:393-396.
74. Pyr Dit Ruys S., Wang X., Smith E.M., Herinckx G., Hussain N., Rider M.H., et al. Identification of autophosphorylation sites in eukaryotic elongation factor-2 kinase. Biochem J 2012, 442:681-692.
75. Redpath N.T., Proud C.G. Cyclic AMP-dependent protein kinase phosphorylates rabbit reticulocyte elongation factor-2 kinase and induces calcium- independent activity. Biochem J 1993, 293:31-34.
76. Redpath N.T., Proud C.G. Purification and phosphorylation of elongation factor-2 kinase from rabbit reticulocytes. Eur J Biochem 1993, 212:511-520.
77. Reissner K.J., Shobe J.L., Carew T.J. Molecular nodes in memory processing: insights from Aplysia. Cell Mol Life Sci 2006, 63:963-974.
78. Rellos P., Pike A.C., Niesen F.H., Salah E., Lee W.H., von D.F., et al. Structure of the CaMKIIdelta/calmodulin complex reveals the molecular mechanism of CaMKII kinase activation. PLoS Biol 2010, 8. e1000426.
79. Romero-Ruiz A., Bautista L., Navarro V., Heras-Garvin A., March-Diaz R., Castellano A., et al. Prolyl hydroxylase-dependent modulation of eukaryotic elongation factor 2 activity and protein translation under acute hypoxia. J Biol Chem 2012, 287:9651-9658.
80. Rose A.J., Broholm C., Kiillerich K., Finn S.G., Proud C.G., Rider M.H., et al. Exercise rapidly increases eukaryotic elongation factor 2 phosphorylation in skeletal muscle of men. J Physiol 2005, 569:223-228.
81. Rose A.J., Alsted T.J., Jensen T.E., Kobbero J.B., Maarbjerg S.J., Jensen J., et al. A Ca(2+)-calmodulin-eEF2K-eEF2 signalling cascade, but not AMPK, contributes to the suppression of skeletal muscle protein synthesis during contractions. J Physiol 2009, 587:1547-1563.
82. 2+/calmodulin-dependent system of protein phosphorylation. Biochimie 1988, 70:619-626.
83. Ryazanov A.G., Pavur K.S., Dorovkov M.V. Alpha kinases: a new class of protein kinases with a novel catalytic domain. Curr Biol 1999, 9:R43-R45.
84. Ryazanov A.G. Elongation factor-2 kinase and its newly discovered relatives. FEBS Lett 2002, 514:26-29.
85. 2+/calmodulin-dependent protein kinase III) messenger RNA in developing mouse brain. Neurosci Lett 2002, 330:41-44.
86. Scheetz A.J., Nairn A.C., Constantine-Paton M. N-methyl-d-aspartate receptor activation and visual activity induce elongation factor-2 phosphorylation in amphibian tecta: a role for N-methyl-d-aspartate receptors in controlling protein synthesis. Proc Natl Acad Sci USA 1997, 94:14770-14775.
87. Scheetz A.J., Nairn A.C., Constantine-Paton M. NMDA-mediated control of protein synthesis at developing synapses. Nature Neuroscience 2000, 3:1-7.
88. Schwanhausser B., Busse D., Li N., Dittmar G., Schuchhardt J., Wolf J., et al. Global quantification of mammalian gene expression control. Nature 2011, 473:337-342.
89. Seibt J., Dumoulin M.C., Aton S.J., Coleman T., Watson A., Naidoo N., et al. Protein synthesis during sleep consolidates cortical plasticity in vivo. Curr Biol 2012, 22:676-682.
90. Shepherd J.D., Bear M.F. New views of arc, a master regulator of synaptic plasticity. Nat Neurosci 2011, 14:279-284.
91. Smith E.M., Proud C.G. cdc2-Cyclin B regulates eEF2 kinase activity in a cell cycle- and amino acid-dependent manner. EMBO J 2008, 27:1005-1016.
92. Steward O., Levy W.B. Preferential localization of polyribosomes under the base of dendritic spines in granule cells of the dentate gyrus. J Neurosci 1982, 2:284-291.
93. Sutton M.A., Taylor A.M., Ito H.T., Pham A., Schuman E.M. Postsynaptic decoding of neural activity: eEF2 as a biochemical sensor coupling miniature synaptic transmission to local protein synthesis. Neuron 2007, 55:648-661.
94. Taha E., Gildish I., Gal-Ben-Ari S., Rosenblum K. The role of eEF2 pathway in learning and synaptic plasticity. Neurobiol Learn Mem 2013, 105:100-106.
95. Takei N., Kawamura M., Ishizuka Y., Kakiya N., Inamura N., Namba H., et al. Brain-derived neurotrophic factor enhances the basal rate of protein synthesis by increasing active eukaryotic elongation factor 2 levels and promoting translation elongation in cortical neurons. J Biol Chem 2009, 284:26340-26348.
96. Tavares C.D., O'Brien J.P., Abramczyk O., Devkota A.K., Shores K.S., Ferguson S.B., et al. Calcium/calmodulin stimulates the autophosphorylation of elongation factor 2 kinase on Thr-348 and Ser-500 to regulate its activity and calcium dependence. Biochemistry 2012, 51:2232-2245.
97. Teige M., Scheikl E., Reiser V., Ruis H., Ammerer G. Rck2, a member of the calmodulin-protein kinase family, links protein synthesis to high osmolarity MAP kinase signaling in budding yeast. Proc Natl Acad Sci U S A 2001, 98:5625-5630.
98. Tekedereli I., Alpay S.N., Tavares C.D., Cobanoglu Z.E., Kaoud T.S., Sahin I., et al. Targeted silencing of elongation factor 2 kinase suppresses growth and sensitizes tumors to Doxorubicin in an orthotopic model of breast cancer. PLoS ONE 2012, 7. e41171.
99. Terai K., Hiramoto Y., Masaki M., Sugiyama S., Kuroda T., Hori M., et al. AMP-activated protein kinase protects cardiomyocytes against hypoxic injury through attenuation of endoplasmic reticulum stress. Mol Cell Biol 2005, 25:9554-9575.
100. Verpelli C., Piccoli G., Zanchi A., Gardoni F., Huang K., Brambilla D., et al. Synaptic activity controls dendritic spine morphology by modulating eEF2-dependent BDNF synthesis. J Neurosci 2010, 30:5830-5842.
101. Walden W.E., Thach R.E. Translational control of gene expression in a normal fibroblast. Characterization of a subclass of mRNAs with unusual kinetic properties. Biochemistry 1986, 25:2033-2041.
102. RSK1 and p70 S6 kinase. EMBO J 2001, 20:4370-4379.
103. Weatherill D.B., McCamphill P.K., Pethoukov E., Dunn T.W., Fan X., Sossin W.S. Compartment-specific, differential regulation of eukaryotic elongation factor 2 and its kinase within aplysia sensory neurons. J Neurochem 2011, 117:841-855.
104. White S.J., Kasman L.M., Kelly M.M., Lu P., Spruill L., McDermott P.J., et al. Doxorubicin generates a proapoptotic phenotype by phosphorylation of elongation factor 2. Free Radic Biol Med 2007, 43:1313-1321.
105. Wiseman S.L., Shimizu Y., Palfrey C., Nairn A.C. Proteasomal degradation of eukaryotic elongation factor-2 kinase (EF2K) is regulated by cAMP-PKA signaling and the SCFbetaTRCP ubiquitin E3 ligase. J Biol Chem 2013, 288:17803-17811.
106. Wu H., Yang J.M., Jin S., Zhang H., Hait W.N. Elongation factor-2 kinase regulates autophagy in human glioblastoma cells. Cancer Res 2006, 66:3015-3023.
107. Wu H., Zhu H., Liu D.X., Niu T.K., Ren X., Patel R., et al. Silencing of elongation factor-2 kinase potentiates the effect of 2-deoxy-d-glucose against human glioma cells through blunting of autophagy. Cancer Res 2009, 69:2453-2460.
108. Yamaguchi H., Matsushita M., Nairn A.C., Kuriyan J. Crystal structure of the atypical protein kinase domain of a TRP channel with phosphotransferase activity. Mol Cell 2001, 7:1047-1057.
109. Yang J., Yang J.M., Iannone M., Shih W.J., Lin Y., Hait W.N. Disruption of the EF-2 kinase/Hsp90 protein complex: a possible mechanism to inhibit glioblastoma by geldanamycin. Cancer Res 2001, 61:4010-4016.
110. Ye Q., Crawley S.W., Yang Y., Cote G.P., Jia Z. Crystal structure of the alpha-kinase domain of Dictyostelium myosin heavy chain kinase A. Sci Signal 2010, 3. ra17.